Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia



Status:Completed
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:25 - 65
Updated:7/21/2018
Start Date:November 21, 2013
End Date:June 30, 2018

Use our guide to learn which trials are right for you!

Cognitive dysfunction is a major contributor to the poor community outcome of individuals
with schizophrenia. Developing more effective cognitive remediation interventions is
imperative to improve the daily lives of affected subjects and reduce the disability of this
illness. The goal of this clinical trial is to evaluate two types of cognitive training
approaches to determine which one is more beneficial for individuals with schizophrenia. This
study also uses electrophysiological techniques to gain a better understanding of the
mechanisms involved in cognitive remediation. Findings from this study will provide
information about how to design the most optimally efficient cognitive training intervention
to improve the cognitive and social functioning of patients with severe mental illness.

Schizophrenia is a disorder that affects both higher-level neurocognitive operations (e.g.,
verbal memory, executive functioning) and lower-level perceptual processes (e.g., auditory
processing). These deficits contribute to the poor community outcome and severe functional
disability seen in patients. Effectively treating the cognitive dysfunction associated with
this illness is important to achieve improvements in daily functioning. Recent meta-analytic
studies report that cognitive training in schizophrenia has a moderate effect-size impact on
cognitive functioning and a lower impact on daily functioning. However, most training
interventions for schizophrenia have only targeted higher-order cognitive processes. A few
recent interventions have targeted basic perceptual processing and shown that auditory and
visual perceptual abilities can be trained and improved in patients with schizophrenia. These
findings suggest that basic perceptual processing may be an ideal target for intervention. At
this point, it is still unclear whether a neuroplasticity-based, bottom-up intervention is
more effective than an intervention that targets top-down functions like attention, working
memory, and executive functioning.

This clinical trial will contrast a bottom-up intervention targeting basic auditory processes
and a top-down intervention targeting higher-order cognitive functions, compared with a
control condition, in Veterans with schizophrenia. These interventions will be assessed by
their effects on representative measures from three outcome domains: 1) neurocognition, 2)
electroencephalography (EEG), and 3) functional capacity. Participants will be randomly
assigned to the bottom-up auditory training, top-down cognitive training, or control
treatment (commercial computer games). All treatments will be administered three times a week
(1 hour each) for 12 weeks. A comprehensive battery of cognitive, electrophysiological, and
functional measures will be administered at baseline, 6 weeks, and at completion of
treatment. The investigators will enroll 120 Veterans with schizophrenia or schizoaffective
disorder across the 5 years of the study.

This study will determine which training approach leads to the largest magnitude of
improvement in neurocognition, functional capacity, and neural functioning measured with EEG.
Moreover, it will shed light on the neural mechanisms underlying the response to training. By
determining whether it is more beneficial to treat lower-level perceptual processes or
higher-level cognitive functions, the results of this project will inform future
recovery-based cognitive remediation interventions for Veterans with schizophrenia.

Inclusion Criteria:

- Veterans with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder

- Between 25 and 65 years of age

- Estimated premorbid IQ > 70 (based on reading ability)

- Understand spoken English sufficiently to comprehend the consent form

- Clinically stable (i.e., no inpatient hospitalization in the 3 months, no changes in
psychiatric medications in the 6 weeks, and no changes in housing in the 2 months,
prior to enrollment)

Exclusion Criteria:

- Documented history of mental retardation or severe learning disability

- Clinically significant neurological disease as determined by medical history (e.g.,
epilepsy, stroke)

- History of serious head injury with loss of consciousness greater than 1 hour and
concomitant neuropsychological sequelae

- Meeting DSM-IV criteria for drug or alcohol dependence during the 6 months, or abuse
during the month preceding study enrollment
We found this trial at
2
sites
West Los Angeles, California 90073
Principal Investigator: Carol Jahchan, PhD
Phone: 310-478-3711
?
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
10940 Ayres Avenue
Los Angeles, California 90073
Phone: 310-478-3711
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials